International Cannabis Weekly: 451

CANNABIS EUROPA LONDON 2026 – KEY INSIGHTS, DAY 1

Cannabis Europa London is back at The Barbican Centre for two days of conversations with global cannabis leaders, policymakers, industry analysts and patient representatives, and, as ever, the sun has shown up.

READ MORE  »

CANNABIS EUROPA LONDON, 2026: KEY INSIGHTS, DAY 2

READ MORE »

BUSINESS OF CANNABIS AWARDS 2026: OUR WINNERS

READ MORE »

• Tilray Medical Europe named silver partner for Cannabis Europa London 2026.
• Jersey’s cannabis industry posts first profit as exports triple despite concerns over value leakage.
• France strengthens position as Europe’s leading industrial hemp producer and exporter.
• Germany sees growing reimbursement demand for medical cannabis flower prescriptions nationwide.
• Spanish and Portuguese regions launch cross-border hemp value chain development initiative.
• Bedrocan launches cannabis flower concentrate designed for magistral pharmaceutical formulations in Portugal.
• Cannabis Europa London 2026 day two highlights major trends shaping European cannabis markets.
• German CDU drug commissioner expresses support for recreational cannabis pilot programmes.
• Pharmaceutical products expected to dominate Europe’s shrinking and tightly regulated CBD sector.
• Why are UK CBD wellness shares facing fresh AIM pressures? Read the analysis here.

GET TICKETS »

• Vast majority of Americans now support cannabis legalisation according to new Pew poll.
• Congressional committee advances bill to create cannabis impairment testing standards and guidelines.
• Massachusetts regulators to begin auditing THC potency claims listed on cannabis product labels.
• FundCanna secures $60 million credit facility to expand cannabis industry lending operations.
• SYM Sciences awarded $50,000 grant to advance cannabinoid research and development platform.
• Curaleaf is preparing for uplisting effort on some major United States stock exchanges.
• Prescription cannabis telehealth platform launches in Colorado with multistate expansion plans underway.
• SeedBanks.com launches global directory for cannabis genetics and seedbank discovery.

• GØ Brands expands portfolio to accelerate development of the light cannabis category.
• Herbal Dispatch secures Export Development Canada insurance to support international expansion strategy.
• Arbitrator upholds Air Transat’s zero-tolerance workplace policy on cannabis consumption.
• Decibel reports 41 percent year-over-year revenue growth in first quarter 2026 results.
• Edmonton cannabis cafe urges lawmakers to loosen restrictions on on-site cannabis sales.
• Cannabis vape product recalled in Canada due to incorrect THC labelling concerns.
• Canadian cannabis retail sales continued climbing higher during March 2026 reporting period.

• Brazilian experts call for higher THC limits in industrial hemp suited to tropical climates.
• Fiocruz supports Mato Grosso do Sul association researching medical cannabis and public access.
• Colombian election candidates outline differing positions on marijuana and cannabis regulation policies.
• Tierra del Fuego strengthens regional medical cannabis programme and patient access initiatives.
• Brazilian medical cannabis congress highlights chemistry and regulation as key industry pillars.
• Antigua and Barbuda medicinal cannabis authority educates police recruits on cannabis legislation.

• ASX-listed medicinal cannabis stocks face evolving market dynamics and investor sentiment shifts.
• TSA rules and state laws continue creating confusion around medical cannabis at airports.
• Avecho receives AU$1.98 million research and development tax incentive payment in Australia.
• Thailand’s cannabis market remains resilient despite impact of newly introduced regulations.

• Cheeba Cannabis Summit returns to Johannesburg to support growth of the cannabis economy.